Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

Your search for ‘Smart & Biggar’ returned 2,497 results

Use advanced search filters to refine your search

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Rare Interlocutory Injunction Issued by Federal Court in Trademark Case

    In a significant decision issued yesterday, Sleep Country Canada Inc v Sears Canada Inc, 2017 FC 148, the Federal Court issued rare interlocutory relief to a Plaintiff in a trademark case.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    IP Update — Canada: French Language Requirements In Québec: Part 3

    This series will examine the French language requirements for commerce and business in the province of Québec and provide practical guidance on how brand owners can navigate these requirements.
    CanadaMedia, Telecoms, IT, Entertainment
    Smart & Biggar
Smart & Biggar
  • Article

    Guidance Document - Use Of A Foreign-Sourced Reference Product As CRP

    On November 27, 2017, Health Canada announced the release of Guidance Document: Use of a Foreign-sourced Reference Product as a Canadian Reference Product.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Ontario Court Of Appeal Dismisses Appeal Of Judgment Awarding Apotex Damages From Contract Research Organization For Delayed FDA approval Of Two Products

    As previously reported, in December 2017, Apotex was awarded over $11M in damages and pre-judgment interest for losses flowing from delays ...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    COVID-19 Update: Canadian Intellectual Property Office Deadlines Extended Until July 6, 2020

    In view of the ongoing COVID-19 pandemic, the Canadian Intellectual Property Office (CIPO) has further extended patent, trademark, and industrial design
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Divided Success In Sandoz's Motion To Strike Monetary Remedies And Other Novel Claims In Rituximab PMNOC Actions

    A Federal Court Order has issued on a motion to strike brought by Sandoz in four actions relating to infringement of rituximab patents.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Competition Bureau Releases Updated Intellectual Property Enforcement Guidelines

    On March 31, 2016, the Competition Bureau ("Bureau") released a final updated version of its Intellectual Property Enforcement Guidelines ("IPEGs") following an extensive public consultation process held in 2015.
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    Consultation On Draft Guidance Governing Public Release Of Clinical Information Contained In Drug Submissions And Medical Device Applications

    Implementation will occur in 4 phases to take place over 4 years.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Dow Obtains Largest Canadian Patent Infringement Award In History

    The Federal Court has issued its Further Judgment and Reasons concerning the amount of financial compensation to be paid to the Dow Chemical Company as a result of earlier patent infringement...
    CanadaIntellectual Property
    Smart & Biggar
    Smart & Biggar
  • Article

    JAMP Seeks To Bring Abuse Of Dominance Case Re: STELARA

    JAMP filed an application with the Competition Tribunal on July 26, 2024, seeking leave to bring an abuse of dominance case against Janssen relating to ustekinumab (Janssen's STELARA).
    CanadaAntitrust/Competition Law
    Smart & Biggar
    Smart & Biggar
  • Article

    Moose Knuckles Settles Misleading Advertising Case With $750,000 Charitable Donation

    On April 28, 2016, we first reported on the Competition Bureau's legal proceedings against Canadian based parka manufacturer, Moose Knuckles, concerning allegedly misleading claims...
    CanadaAntitrust/Competition Law
    Smart & Biggar
    Smart & Biggar
  • Article

    Ticketmaster To Pay Hefty Penalty For Misleading Pricing Practices

    On June 27, 2019, the Competition Bureau reached an agreement with Ticketmaster and related companies. Under the agreement, Ticketmaster L.L.C.,
    CanadaAntitrust/Competition Law
    Smart & Biggar
    Smart & Biggar
  • Article

    VW And Audi Face Hefty Fines For Misleading Environmental Marketing Claims

    On December 19, 2016, the Canadian side of the diesel engine saga plaguing VW and Audi came to a close when the federal Competition Bureau reached a consent agreement for a $15 million administrative...
    CanadaAntitrust/Competition Law
    Smart & Biggar
    Smart & Biggar
  • Article

    Judgment Granted After Summary Trial For Recidivist Sale Of Counterfeits

    Chanel S de R.L., et al. v Lam Chan Kee Company Ltd., et al. 2015 FC 1091, is a case involving counterfeit CHANEL® goods.
    CanadaCriminal Law
    Smart & Biggar
    Smart & Biggar
  • Article

    CADTH Releases The 4th Edition Of The Guidelines For Economic Evaluation Of Health Technologies: Canada

    On March 28, 2017, CADTH published the fourth edition of the Guidelines for Economic Evaluation of Health Technologies: Canada, which set out the best practices for determining the economic value of health technologies.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Canadian Institute For Health Information (CIHI) And Patented Medicine Prices Review Board (PMPRB) Report Upward Trend Of High-Cost Drugs

    CIHI: On December 17, the Canadian Institute for Health Information (CIHI) published statistics on drug spending, finding that in 2018, around 40% of drug spending was...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Do You Want Fries Or Salad With That? Ontario Passes Act Requiring Labelling Of Calories On Food And Drink Menus

    In particular, these food service establishments will be required to display the number of calories in each size and variety of food and drink item offered, as well as "any other information" required by the regulations.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Federal Court Dismisses AstraZeneca's Prohibition Application Against Mylan's Naproxen-Esomeprazole Magnesium Tablet Product

    The Court found that Mylan's allegation of invalidity on the basis of obviousness was justified.
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    House Of Commons Standing Committee On Health Meets For Study Of The PMPRB

    The Standing Committee on Health (HESA) of the House of Commons met on Thursday, April 27, 2023, to begin its study of the Patented Medicine Prices Review Board (PMPRB).
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Article

    Janssen Seeks Leave From Supreme Court Of Canada Re: INFLECTRA Biosimilar Decision

    On March 30, 2020, Kennedy and Janssen applied to the Supreme Court of Canada for leave to appeal a Federal Court of Appeal decision relating to Kennedy's patent covering uses of REMICADE...
    CanadaFood, Drugs, Healthcare, Life Sciences
    Smart & Biggar
    Smart & Biggar
  • Showing 141–160 of 2497 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics